Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
Decoy Therapeutics nominated Patricia Gauthier for election as a Class II director at its upcoming annual meeting. Gauthier brings extensive commercial and operational experience from Moderna, GSK, and the Canadian government, replacing outgoing director David Arthur.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.